Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 2, Status: Authorised
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 June 2025
Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 1, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Biobhyo, Swine dysentery vaccine (inactivated), Status: Opinion
Veterinary medicines European public assessment report (EPAR): Bravecto CombiUNO, fluralaner,milbemycin oxime, Status: Opinion
Veterinary medicines European public assessment report (EPAR): Zenrelia, ilunocitinib, Status: Opinion
Summary of opinion: Poulvac E. coli, 12/06/2025 Negative
Summary of opinion: NexGard, 12/06/2025 Positive
Summary of opinion: Nexgard Spectra, 12/06/2025 Positive